NIH-funded research Career grant

Finding new ways to improve T cell development for better immune therapies

Official title: Identification of Novel Epigenetic Regulators of lymphocyte Development

Funded at Boston Children's Hospital · NIH-10914259 · Data updated 2026-11-12

This study is looking at how certain factors affect the growth of T cells, which are important for our immune system, using special stem cells to find new ways to help create better T cells for treating diseases like cancer and autoimmune disorders.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$154,138
NIH project number5K99HL170075-02
Project IDNIH-10914259 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that could benefit from enhanced T cell therapies, such as cancer or autoimmune diseases.

Less likely to help

Patients with conditions unrelated to T cell function or those who do not require T cell-based therapies may not benefit from this research.

What this research studies

This research investigates how epigenetic factors influence the development of T cells, which are crucial for the immune system. By using human induced pluripotent stem cells (iPSCs), the team aims to identify novel mechanisms that regulate T cell differentiation. The approach includes screening small molecules during various stages of T cell development to discover new epigenetic regulators. This could lead to improved methods for generating functional T cells for therapies targeting diseases like cancer and autoimmune disorders.

Why it matters

Potential benefit: If successful, this research could enhance the effectiveness of T cell therapies, providing better treatment options for patients with immune-related diseases.

How similar studies have gone: Other research has shown promise in using epigenetic modulation to improve T cell development, indicating that this approach may lead to significant advancements.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Jing, Ran — Boston Children's Hospital
  • Study coordinator: Jing, Ran

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.